Erectile Dysfunction Flashcards

1
Q

What is erectile dysfunction?

A

Persistent (at least 6 months) inability to achieve or maintain an erection of sufficient duration and firmness to complete satisfactory sexual intercourse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ED incidence increasing with ___

A

Age

around 50% of men 40yo and older experience ED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the physiology of an erection

A

Flaccid state
- Arterial blood flow into penis = Venous blood flow out of penis

During erection
- Blood inflow > Blood flow out of penis

MOA of erection:
- Sexual arousal causes nerve to release chemicals that increase arterial flow into penis - Smooth muscle relaxes, corpora cavernosa fills up with blood, spongy muscle tissue relaxes and traps blood, makes penis firm
- Swelling causes compression of venules against tunica albuginea, which decreases venous outflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 2 systems that play a role in the physiology of an erection?

A
  1. Activated parasympathetic system
  2. Functional hormonal system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does activation of parasympathetic system lead to an erection?

A

Sexual arousal causes acetylcholine release

  1. ACh increases Nitric Oxide (NO) which increases the activity of guanylate cyclase, and increases cyclic guanosine monophosphate (cGMP)
  2. ACh and Prostaglandins E increases adenyl cyclase, which increases cyclic adenosine monophosphate (cAMP)

cGMP and cAMP cause smooth muscle relaxation and vasodilation, hence increase blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does the functional hormonal system lead to an erection?

A

Testosterone encourages libido

Usual normal serum conc. of T: 300-1000ng/dL (10.4 - 38.2 nmol/L)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the relationship between Testosterone levels and ED

A

Low testosterone does not mean ED

Normal testosterone can have ED

Hence, testosterone levels are only assessed in the perspective of presence of ED symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the physiology of Detumescence
(3 pathways)

A
  1. Deactivating of parasympathetic system
    - cGMP deactivated by PDE-5 to 5-GMP (predominantly found in penis)
    - stops the vasodilation and blood inflow
  2. Activated sympathetic system
    - induces smooth muscle contraction via a2 adrenergic receptors of arterioles resulting in a reduction of blood flow
  3. Serotonin
    - inhibitory effect on sexual arousal
    - recall that a possible SE of SSRI is ED
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 4 etiology of ED?

A
  1. Organic ED (80%) - vascular, nervous, hormonal systems compromised, or medication induced
  2. Psychogenic ED - due to thoughts, feelings (e.g., malaise, loss of attraction, stress, performance anxiety, mental disorders, sedation)
  3. Mixed ED
  4. Others - social habits (smoking, alcohol, illicit drug use), obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Organic ED

Discuss the vascular causes of ED

A

Arteriosclerosis
Peripheral vascular disease
Hypertension
Diabetes (DM)

=> Associated with narrowed blood vessels, reduced inflow of blood to penis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Organic ED

Discuss the hormonal causes of ED

A

Hypogonadism - insufficient testosterone

Hyperprolactinemia - too much prolactin suppresses testosterone production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Organic ED

Discuss the nervous system causes of ED

A

Central: Spinal cord trauma or disorders, stroke, CNS tumors

Peripheral: Diabetes, Neuropathy, Urethral surgery

=> Associated with loss of sensation, nerve damage, nerve signals from brain or spinal cord do not reach penis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List examples of medication induced ED

A B C D 5 S

A
  1. Clonidine, Methyldopa, BB (except Nevibolol), Thiazide diuretics
  2. Anticholinergics (TCA, 1st gen antihistamines, phenothiazines)
  3. Dopamine antagonist (e.g., metoclopramide)
  4. Serotonin Selective Reuptake Inhibitors
  5. Finasteride, Dutasteride
  6. CNS depressants (e.g., Benzodiazepines, anticonvulsants)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. Clonidine, Methyldopa, BB (except Nevibolol), Thiazide diuretics

Explain MOA of ED, and alternatives

A

These are blood pressure (HTN) medications

MOA: Decrease penile blood flow

Alternatives: Nevibolol, ACEi, ARB, Loop diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. Anticholinergics (TCA, 1st gen antihistamines, phenothiazines)

Explain MOA of ED, and alternatives

A

MOA: Anticholinergics decrease Acetylcholine activity, decrease parasympathetic activation

Alternatives: Bupropion, trazodone, 2nd gen antihistamines, 2nd gen atypical antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. Dopamine antagonist (e.g., metoclopramide)

Explain MOA of ED, and alternatives

A

MOA: Dopamine causes sexual arousal and stimulation, hence antagonist reduces this

Alternatives: PPIs, erythromycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
  1. Serotonin Selective Reuptake Inhibitors

Explain MOA of ED, and alternatives

A

MOA: Increased serotonin in brain, serotonin has inhibitory effect on sexual arousal. Also decrease testosterone

Alternatives: Bupropion, Trazodone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  1. Finasteride, Dutasteride

Explain MOA of ED, and alternatives

A

MOA: decrease testosterone

Alternatives: (for BPH) Terazosin, Alfurosin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. CNS depressants (e.g., Benzodiazepines, anticonvulsants)

Explain MOA of ED, and alternatives

A

MOA: Suppress perception of psychic stimulus

Alternatives: Anticonvulsants (Valproic acid, Gabapentin) *less drowsy options

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some complications of ED?

A
  1. Inability to achieve erection
  2. Loss of interest in sexual activities
  3. Depression
  4. Performance anxiety
  5. Embarrassment
  6. Angry
  7. Low self-esteem
  8. Disharmony in rsp
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the parameters for evaluation of ED?

A
  1. Signs and symptoms
  2. SHIM score
  3. Workup to identify underlying causes of ED - medical, social, surgical history, lab results (BG, lipid, testosterone etc.)
  4. Evaluation for cardiovascular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Explain the Sexual Health Inventory for Men (SHIM) scoring system

A

Mild to no ED: 17-21 points
Moderate to severe: <11 points

*Lower points, severity increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Why should CV evaluation be conducted in all patients with ED?

A
  • ED might be an early symptom of unidentified comorbid CVD (think impaired blood flow to penis)
  • As such, impt to evaluate as sexual activity activates the sympathetic system, incr BP and HR, may incr risk of myocardial infarction

=> If low risk of CVD: can engage in sexual activity
=> If unknown/not low risk: exercise stress test to evaluate exercise capacity
=> If unstable or severe symptomatic CVD: defer until condition stabilized

24
Q

What can be done to reduce the risk of CV complications with sexual activity?

A

Cardiac rehabilitation and regular exercise

25
Q

Management of ED

What is the first step in the management of ED, before non-pharmacologicals and pharmacologicals are used?

A

Recognise, reverse, and treat the underlying cause

E.g., vascular, nervous, hormonal, medication-induced, psychological (include loss of attraction)

26
Q

Management of ED

What are some non-pharmacological methods?

A
  • Address modifiable risk factors (smoking, weight, BG, BP, lipids, exercise, alcohol)
  • Psychotherapy (counseling, performance anxiety)
  • Devices: vacuum erection device (VEDs)
  • Surgery: penile implant
27
Q

Management of ED

What is the first line agent in the management of ED?

A

phosphodiesterase type 5 inhibitors (PDE5i)

28
Q

Management of ED

What is the MOA of PDE5i?

A

MOA: inhibit the deactivation of cGMP by enzyme PDE5 to 5’GMP, which will increase cGMP, cause smooth muscle relaxation and vasodilation, increase blood flow to the corpora cavernosa, causing an erection

29
Q

Management of ED

PDE5i causes an erection only after _______

A

After sexual stimulation

30
Q

Management of ED

What is the failure rate of PDE5i

A

Failure rate 30-40% (similar across all agents in the class)

May need to try several times (5-6 times) to work, do not give up after one dose

31
Q

Management of ED

What are the 4 agents in PDE5i class

A

Sildenafil
Vardenafil
Tadalafil
Avanafil

*They have similar efficacy, but diff onset, duration of action, and SE profile

32
Q

Management of ED

Which of the 4 PDE5i agents has the longest duration of action and can be taken daily?

A

Tadalafil
- Duration of action of 36h
- Can take 2.5-5mg PO daily
- Can be taken up to 36h before intercourse (hence regardless of sexual activity)

*The rest are taken PRN only

33
Q

Management of ED

What are the timings to take each PDE5i agent before sexual intercourse?
Also state their onset of action and duration of action.

A

Sildenafil - 50mg 1h before intercourse, onset: 15-60min, DOA: 4h
Vardenafil - 10mg 1h before intercourse, onset: 25-60min, DOA: 4h
Tadalafil - 5mg up to 36h before intercourse, onset: 15min-2h, DOA: 36h
Avanafil - 100mg 30min before intercourse, onset: 15-30min, DOA: 6h

34
Q

Management of ED

Which of the 4 PDE5i agents must be taken on empty stomach?

A

Sildenafil and Vardenafil

*Tadalafil and Avanafil can be taken regardless of food

35
Q

Management of ED

Which of the 4 PDE5i agents require hepatic and/or renal dosage adjustments?

A

Sildenafil - hepatic and renal
Vardenafil - hepatic
Tadalafil - hepatic and renal
Avanafil - nil

36
Q

Management of ED

In what groups of patient should a lower dose of PDE5i be used?

A
  • Patients >=65yo
  • Those taking alpha blockers (*hypotension)
  • Patients with renal failure (*PDE5i may be renally excreted)
  • Patients taking CYP3A4 inhibitors (PDE5i is a CYP3A4 substrate)

E.g., of CYP3A4 inhibitors
- macrolides
- azoles
- grapefruit
- cimetidine
- ritonavir
- saquinavir

37
Q

Management of ED

What are the side effects of PDE5i?

A
  1. SEs due to vasodilation: Headache, rhinitis, flushing, muscle and back pain, dizziness, hypotension, dyspepsia
  2. Prolong erection and priapism
    - seek emergency department treatment if >4h
  3. Sudden hearing loss, may present with tinnitus and dizziness (rare)
    - seek medical attention
  4. QTc prolongation
    - Vardenafil
  5. Muscle pain
    - Tadalafil (PDE11 affinity)
  6. Ocular problems
    - Sildenafil and Vardenafil (PDE6 affinity in retina)
    - Reversible color discrimination, blue green tinting, blur vision
    - Sensitivity to light
    - Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
38
Q

Management of ED

Which PDE5i agent can cause QTc prolongation?

A

Vardenafil (QV)

39
Q

Management of ED

Which PDE5i agent can cause muscle pain? (due to affinity for?)

A

Tadalafil (MT)
- due to PDE11 affinity

40
Q

Management of ED

Which PDE5i agents can cause ocular problems? (due to affinity for?)

A

Sildenafil and Vardenafil (VOS)
- PDE6 affinity in retina

41
Q

Management of ED

What is Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), a possible ocular problem with Sildenafil or Vardenafil?

What are the risk factors for NAION?

A

NAION
- Blood flow to optic nerve is blocked
- Cause sudden decreased vision or vision loss
- Stop use and seek medical attention immediately

Risk factors:
- DM
- Smoking
- HTN
- CVD
- Dyslipidemia
- Age >50yo

42
Q

Management of ED

What are the possible DDIs with PDE5i?

A
  1. Nitrates (e.g., sublinual GTN to prevent MI)
    - Life-threatening hypotension
    - Potentiate vasodilation effect of GTN via incr cGMP due to concomitant blockade of cGMP degradation
  2. Antihypertensive (including alpha-1 blockers)
    - Hypotenstion
  3. Alcohol
    - Hypotenstion
  4. CYP3A4 inhibitors
    - Incr serum concentration of PDE5i (require lower dose)
43
Q

Management of ED

What are the timing administrations if patient is on PDE5i and Nitrates?

A

Sildenafil - avoid nitrates for 24h after administration of Sildenafil
Vardenafil - avoid nitrates for 24h after administration of Vardenafil
Tadalafil - avoid nitrates for 48h after administration of Tadalafil
Avanafil - avoid nitrates for 12h after administration of Avanafil

44
Q

Management of ED

How to monitor efficacy of PDE5i?

A

If failure reported,
- Assess whether patient has tried 5-6 times
- Administration with food
- Timing and frequency of dosing
- Lack of sexual stimulation
- Titration to max dose

If all modifiable factors addressed,
- Treat with a different PDE5i
- Proceed with more invasive therapy (e.g., device, surgical implant)

45
Q

Management of ED

What safety monitoring parameters should be monitored for PDE5i?

A
  • BP (watch for hypotension)
  • Side effects (esp life-threatening - priapism, hearing loss, vision loss, QTc prolongation)
  • Drug interactions
46
Q

Management of ED

Apart from efficacy and safety of PDE5i, what else should be monitored?

A

Changes in cardiac health status (evaluate CVD)

47
Q

Management of ED

When is testosterone replacement indicated for patient with ED?

A

Indicated as 1st line for patient with ED and SYMPTOMATIC hypogonadism, as confirmed by decreased libido AND low serum T conc.

48
Q

Management of ED

What is the normal serum testosterone range?

A

300-1100ng/dL (10.4-38.2nmol/L)

49
Q

Management of ED

What are the side effects of Testosterone replacement?

A

Irritability
Aggressive behaviour
Undesirable hair growth
Incr BP
Hepatotoxicity
Dyslipidemia
Polycythemia (high conc. of RBC => risk of MI, stroke)
Prostatic hyperplasia (CI for prostate cancer)

50
Q

Management of ED

What are the dosage forms of Testosterone replacement?

A

IM injection (most common in Sg)
Buccal
Patch
Topical gel
Body spray
Nasal spray
Oral tablet

51
Q

Management of ED

What is the monitoring interval for Testosterone levels when on Testosterone replacement?

A

Monitor within 1-3 months after initiation, and at 6-12 month intervals
Discontinue if theres no improvement in the symptoms of ED after 3 months

52
Q

Management of ED

Describe the MOA of Alprostadil

A

Alprostadil MOA: Prostaglandin E1 analog, that (along with acetylcholine) can stimulate adenyl cyclase and increase cAMP, hence inducing smooth muscle relaxation, blood flow into penis, erection

53
Q

Management of ED

Describe the following for Alprostadil
- Onset
- Need for sexual stimulation
- DDIs

A

Onset: 5-10min (fast)

Do not require sexual stimulation to work

DDI: do not use with PDE5i

54
Q

Management of ED

What are the two dosage forms of Alprostadil and their associated SEs

A
  1. Intraurethral Alprostadil
  • Pain, warmth, burning sensation of urethral
  • Voiding difficulties
  • Bleeding, spotting
  • Priapism
  • Partners may experience vaginal burning or itching
  1. Intracavernosal Alprostadil [*preferred due to better efficacy] - inject into side of penis
  • Higher risk of priapism, bleeding, hematoma, fibrosis
  • Disadvantages: fear of needles, invasive, lack of spontaneity, complicated administration technique
55
Q

Management of ED

What drug is not HSA approved, but can be used in other countries for the management of ED?

A

Yohimbine
- alpha-2 antagonist (deactivate sympathetic system, relax smooth muscles)